Entries from HEALTH LAW SECTION BLOG tagged with 'FDA risk/benefit communications'

Drug regulation and investments in it-the Matrixx case

The ‘Questions’ presented in the Supreme Court case Matrixx Initiatives, Inc. et al petitioners v. James Siracusano, et al (No. 09-1156) vary among the documents filed in the case, illustrating the complexity of 21st century drug regulation and investments in...

Feed Subscription

If you use an RSS reader, you can subscribe to a feed of all future entries tagged 'FDA risk/benefit communications'. [What is this?]

Subscribe to feed Subscribe to feed

Other Tags

Other tags used on this blog: